Form 10-Q · Quarterly report
Ulta Beauty 10-Q, filed Aug 27, 2026
- Filed
- CIK
- 0001403568
- Accession no.
- 0001104659-26-102442
Summary
Ulta Beauty reported net sales of $3.04 billion for the 13 weeks ended August 1, 2026, up from $2.79 billion in the same period a year earlier, and $6.20 billion for the 26-week period versus $5.64 billion. The company described its "Ulta Beauty Unleashed" strategy and its international operations through Space NK, a Mexico joint venture, and a Middle East franchise.
Key points
- Net sales for the 13 weeks ended August 1, 2026 were $3.04 billion, compared with $2.79 billion for the 13 weeks ended August 2, 2025.
- Net sales for the 26 weeks ended August 1, 2026 were $6.20 billion, compared with $5.64 billion a year earlier.
- Ulta Beauty said it operates through Ulta U.S., the Space NK luxury beauty subsidiary in the U.K. and Ireland, a joint venture in Mexico, and a franchise in the Middle East.
- The company estimated there are approximately 140 million beauty enthusiasts in the U.S. and said persistent inflationary and macroeconomic pressures have affected consumer spending.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2.Management’s Discussion Overview We were founded in 1990 as a beauty retailer at a time when prestige, mass, and salon products were sold through distinct channels – department stores for prestige products; drug stores and mass merchandisers for mass products; and salons and authorized retail outlets for professional haircare products. We developed a unique specialty retail concept that offers a broad range of brands and price points, select beauty services, and a convenient and welcoming shopping environment. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.